ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,809Medicare Part D Prescriptions Filled, Including Refills

Rank: 919 out of 3647

$538K Total Retail Price of All Prescriptions

Rank: 975 out of 3647

632 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 632 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 632 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 7,339 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
METOPROLOL TARTRATE 372 317 1 7
SIMVASTATIN 361 254 2 1
LISINOPRIL 317 244 3 4
FUROSEMIDE 305 260 4 8
AMLODIPINE BESYLATE 291 250 5 2
LEVOTHYROXINE SODIUM 289 265 6 5
HYDROCODONE-ACETAMINOPHEN 250 118 S3 7 12
WARFARIN SODIUM 214 191 8 15
TRAMADOL HCL 202 143 9 22
OMEPRAZOLE 193 142 10 3
ZOLPIDEM TARTRATE 175 97 11 14
GABAPENTIN 159 124 12 17
CITALOPRAM HBR 119 79 13 25
SERTRALINE HCL 119 80 13 27
TAMSULOSIN HCL 106 88 15 28
NOVOLOG 106 72 15 123
POTASSIUM CHLORIDE 104 83 17 24
DONEPEZIL HCL 103 102 18 30
CIPROFLOXACIN HCL 103 79 18 53
METFORMIN HCL 101 66 20 6
QUETIAPINE FUMARATE 98 76 21 89
PANTOPRAZOLE SODIUM 97 65 22 38
CARVEDILOL 95 68 23 20
DIGOXIN 92 78 24 51
LOSARTAN POTASSIUM 90 84 25 11
GLIPIZIDE 83 68 26 41
PREDNISONE 80 43 27 43
ISOSORBIDE MONONITRATE ER 79 71 28 56
LEVOFLOXACIN 76 64 29 87
ATENOLOL 76 52 29 10
AMOX TR-POTASSIUM CLAVULANATE 74 59 31 118
HYDRALAZINE HCL 71 63 32 81
LEVETIRACETAM 69 29 33 122
OXYBUTYNIN CHLORIDE ER 68 13 34 169
HYDROCHLOROTHIAZIDE 66 66 35 9
ALENDRONATE SODIUM 66 55 35 23
IPRATROPIUM-ALBUTEROL 65 52 37 150
CLOPIDOGREL 64 48 38 26
GLIMEPIRIDE 62 48 39 45
CEPHALEXIN 62 38 39 142
RISPERIDONE 61 40 41 83
FENTANYL 59 29 S2 42 147
MIRTAZAPINE 57 39 43 63
NAMENDA 55 55 44 49
ESCITALOPRAM OXALATE 54 50 45 65
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 43 45 110
ATORVASTATIN CALCIUM 52 44 47 13
FENOFIBRATE 51 33 48 50
LANTUS 50 35 49 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 22, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.